Scotch Corner IPO: What You Should Know Key Project Information Overview

X-twitter Linkedin Facebook-f Vimeo

Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

CVS Group plc

CVS Group refinances £350m debt and launches £50m share buyback

CVS has refinanced its £350m bank facilities on improved terms, launched a £50m share buyback and acquired another small animal practice in Australia...
AstraZeneca

AstraZeneca’s Enhertu recommended for EU approval in HER2-positive solid tumours

AstraZeneca and Daiichi Sankyo’s Enhertu has received a positive CHMP opinion for adults with previously treated unresectable or metastatic HER2-positive solid tumours who have no satisfactory treatment options...

Ethereum’s enterprise network case builds around scale and institutional use

Ethereum’s investor case is shifting from decentralised finance market share to enterprise-scale settlement, Layer-2 growth and institutional adoption...
Brava Health

Brava Health targets demand for smarter personalised healthcare

Brava Health is developing a smarter way for people to manage health data, receive personalised insights and navigate care with greater clarity...
Cizzle Bio

Cizzle Biotechnology sets date for Annual General Meeting

Cizzle Biotechnology has posted its AGM notice to shareholders. The meeting will be held on 16 June 2026 at Shakespeare Martineau LLP’s offices in London...
Cizzle Biotechnology Holdings plc

Cizzle Biotechnology targets early lung cancer detection market

Cizzle Biotechnology is targeting the early lung cancer detection market with a blood-based test aimed at addressing a major unmet medical need...
edx medical

EDX Medical targets AIM growth with ultra-accurate cancer diagnostics

EDX Medical Chief Scientific Officer Professor Chris Evans discusses the company’s AIM admission, prostate cancer testing programme in Scotland, and plans to commercialise a range of advanced diagnostic tests...
Genflow Biosciences Plc

Pet healthspan focus opens a clearer senior care opportunity

Senior pet wellness is gaining relevance as owners focus on helping dogs and cats live better, not just longer...
Verici Dx

Verici Dx publishes clinical validation study for PTRA kidney transplant test

Verici Dx says a clinical validation study published in Kidney360 found its PTRA test outperformed conventional tools in predicting early acute rejection after kidney transplant...
GSK

Japan expands approval of GSK’s Arexvy to at-risk adults aged 18–49

GSK says Japan has expanded Arexvy eligibility to adults aged 18–49 at increased risk of RSV disease, including immunocompromised patients...
AstraZeneca

AstraZeneca and Daiichi Sankyo secure FDA approval for Enhertu in early breast cancer

The FDA has approved AstraZeneca and Daiichi Sankyo’s Enhertu for both neoadjuvant and adjuvant treatment of HER2-positive early breast cancer, based on results from the Phase III DESTINY-Breast11 and DESTINY-Breast05..
Verici Dx Plc

Kidney transplant sector faces push for new therapies and system reform

Transplant specialist Roslyn Mannon says new therapies, organ preservation technologies and transplant system reform are set to reshape kidney transplantation...
Genflow Biosciences Plc

Healthspan moves up the investor agenda

Healthspan is becoming a clearer investor theme as ageing markets shift towards prevention, function and healthier later-life years...
Spire Healthcare plc

Spire Healthcare confirms FY26 outlook after in-line trading

Spire Healthcare said trading for the first four months of 2026 was in line with expectations, with strong private patient revenue growth and FY26 adjusted EBITDA still targeted broadly in..
EDX Medical Group plc

EDX Medical begins trading on AIM following move from Aquis

EDX Medical has commenced trading on the AIM market of the London Stock Exchange under the ticker EDX, highlighting its growth strategy in cancer and infectious disease diagnostics and its..
Genflow Biosciences Plc

Genflow adds delivery expertise through fully funded Acuitas deal

Genflow Biosciences has secured a fully funded delivery collaboration with Acuitas Therapeutics, giving investors a clearer view of how the company plans to advance its SIRT6 gene therapy platform...
GSK plc

GSK partners with SBP Group to support bepirovirsen launch in China

GSK has entered an exclusive collaboration with SBP Group’s CTTQ unit to accelerate the launch of bepirovirsen, a potential first-in-class chronic hepatitis B treatment currently under priority review in China...
IP Group plc

IP Group’s New Chair Designate Signals Confidence in Long Term Growth, Equity Development

IP Group appoints former 3i CEO Michael Queen as Chair Designate as Equity Development highlights significant NAV discount potential...
Ethtry plc

Ethtry invests £500k in Cerulean Winds offshore wind loan

Ethtry Plc commits £500,000 to a senior secured facility supporting Cerulean Winds’ floating offshore wind project, expanding its strategy beyond Ethereum treasury holdings into energy transition investments...
Smith & Nephew plc

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year targets and unveils a new $500m buyback program...

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

Health

CVS Group plc

CVS Group refinances £350m debt and launches £50m share buyback

CVS has refinanced its £350m bank facilities on improved terms, launched a £50m share buyback and acquired another small animal practice in Australia...
AstraZeneca

AstraZeneca’s Enhertu recommended for EU approval in HER2-positive solid tumours

AstraZeneca and Daiichi Sankyo’s Enhertu has received a positive CHMP opinion for adults with previously treated unresectable or metastatic HER2-positive solid tumours who have no satisfactory treatment options...

Ethereum’s enterprise network case builds around scale and institutional use

Ethereum’s investor case is shifting from decentralised finance market share to enterprise-scale settlement, Layer-2 growth and institutional adoption...
Brava Health

Brava Health targets demand for smarter personalised healthcare

Brava Health is developing a smarter way for people to manage health data, receive personalised insights and navigate care with greater clarity...
Cizzle Bio

Cizzle Biotechnology sets date for Annual General Meeting

Cizzle Biotechnology has posted its AGM notice to shareholders. The meeting will be held on 16 June 2026 at Shakespeare Martineau LLP’s offices in London...
Cizzle Biotechnology Holdings plc

Cizzle Biotechnology targets early lung cancer detection market

Cizzle Biotechnology is targeting the early lung cancer detection market with a blood-based test aimed at addressing a major unmet medical need...
edx medical

EDX Medical targets AIM growth with ultra-accurate cancer diagnostics

EDX Medical Chief Scientific Officer Professor Chris Evans discusses the company’s AIM admission, prostate cancer testing programme in Scotland, and plans to commercialise a range of advanced diagnostic tests...
Genflow Biosciences Plc

Pet healthspan focus opens a clearer senior care opportunity

Senior pet wellness is gaining relevance as owners focus on helping dogs and cats live better, not just longer...
Verici Dx

Verici Dx publishes clinical validation study for PTRA kidney transplant test

Verici Dx says a clinical validation study published in Kidney360 found its PTRA test outperformed conventional tools in predicting early acute rejection after kidney transplant...
GSK

Japan expands approval of GSK’s Arexvy to at-risk adults aged 18–49

GSK says Japan has expanded Arexvy eligibility to adults aged 18–49 at increased risk of RSV disease, including immunocompromised patients...
AstraZeneca

AstraZeneca and Daiichi Sankyo secure FDA approval for Enhertu in early breast cancer

The FDA has approved AstraZeneca and Daiichi Sankyo’s Enhertu for both neoadjuvant and adjuvant treatment of HER2-positive early breast cancer, based on results from the Phase III DESTINY-Breast11 and DESTINY-Breast05 trials...
Verici Dx Plc

Kidney transplant sector faces push for new therapies and system reform

Transplant specialist Roslyn Mannon says new therapies, organ preservation technologies and transplant system reform are set to reshape kidney transplantation...
Genflow Biosciences Plc

Healthspan moves up the investor agenda

Healthspan is becoming a clearer investor theme as ageing markets shift towards prevention, function and healthier later-life years...
Spire Healthcare plc

Spire Healthcare confirms FY26 outlook after in-line trading

Spire Healthcare said trading for the first four months of 2026 was in line with expectations, with strong private patient revenue growth and FY26 adjusted EBITDA still targeted broadly in line with FY25...
EDX Medical Group plc

EDX Medical begins trading on AIM following move from Aquis

EDX Medical has commenced trading on the AIM market of the London Stock Exchange under the ticker EDX, highlighting its growth strategy in cancer and infectious disease diagnostics and its expanding portfolio of personalised healthcare technologies...
Genflow Biosciences Plc

Genflow adds delivery expertise through fully funded Acuitas deal

Genflow Biosciences has secured a fully funded delivery collaboration with Acuitas Therapeutics, giving investors a clearer view of how the company plans to advance its SIRT6 gene therapy platform...
GSK plc

GSK partners with SBP Group to support bepirovirsen launch in China

GSK has entered an exclusive collaboration with SBP Group’s CTTQ unit to accelerate the launch of bepirovirsen, a potential first-in-class chronic hepatitis B treatment currently under priority review in China...
IP Group plc

IP Group’s New Chair Designate Signals Confidence in Long Term Growth, Equity Development

IP Group appoints former 3i CEO Michael Queen as Chair Designate as Equity Development highlights significant NAV discount potential...
Ethtry plc

Ethtry invests £500k in Cerulean Winds offshore wind loan

Ethtry Plc commits £500,000 to a senior secured facility supporting Cerulean Winds’ floating offshore wind project, expanding its strategy beyond Ethereum treasury holdings into energy transition investments...
Smith & Nephew plc

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year targets and unveils a new $500m buyback program...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

Health

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple